tumor markers for diagnosing this disease have not been found. erefore, the discovery of novel biomarkers through the application of new methods has become a hotspot in lung cancer research. e aim of this study is to analyze low-molecular-weight metabolites in the serum and urine samples of lung cancer patients and patients with other lung diseases through metabolomics and to explore potential tumor markers further. Methods Both serum and urine samples from 19 lung cancer patients and 15 patients with other lung diseases were subjected to metabolomic analysis using gas chromatography mass spectrometry.
Trans-9-Octadecenoic acid 0.009,524 ↑ 1.60 *Statistical P-value calculated using a two sample t-test (significance at P<0.05); ↑: The level of the metabolites is higher in lung cancer than in other lung diseases; ↓: The level of the metabolites is lower in lung cancer than in other lung diseases.
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